News NeuroMetrix, Inc. BOERSE MUENCHEN

Equities

NLZ0

US6412558800

Real-time BOERSE MUENCHEN Other stock markets 05:43:07 2024-06-28 am EDT			5-day change	1st Jan Change
3.48 ^EUR	0.00%		-1.14%	+0.29%

May. 15	NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

NeuroMetrix Reports Q1 2024 Business Highlights	May. 15	AQ
NeuroMetrix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15	CI
Sector Update: Health Care Stocks Advance Late Afternoon	Apr. 19	MT
Sector Update: Health Care Stocks Rise Friday Afternoon	Apr. 19	MT
NeuroMetrix Says Joshua Horowitz Joining Board, Terminates At-the-Market Equity Facility	Apr. 19	MT
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value	Apr. 19	AQ
Neurometrix, Inc. Appoints Joshua S. Horowitz as a Class III director on the Board	Apr. 19	CI
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	Mar. 20	AQ
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	Mar. 14	AQ
NeuroMetrix, Inc. Announces Publication of Study Demonstrating That DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	Mar. 14	CI
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia	Mar. 13	AQ
Ephraim Fields Discloses his Views on NeuroMetrix	Feb. 27	CI
RS Fund Discloses its Views on NeuroMetrix	Feb. 26	CI
Transcript : NeuroMetrix, Inc., Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights	Feb. 22	AQ
NeuroMetrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22	CI
NeuroMetrix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 22	CI
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call	Feb. 15	AQ
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	Feb. 13	CI
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	Feb. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NeuroMetrix, Inc. BOERSE MUENCHEN

Equities

NLZ0

US6412558800

Summary

Filters